StonvexLoading…
StonvexCore line items from BJ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-05-02 | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 |
|---|---|---|---|---|
Revenue | $5.66B | $21.46B | $15.88B | $10.53B |
Operating Income | $207.91M | $816.60M | $638.53M | $420.18M |
Net Income | $142.73M | $578.38M | $452.52M | $150.71M |
EPS (Diluted) | $1.10 | $4.38 | $3.42 | $2.27 |
Total Assets | $7.93B | $7.51B | $7.55B | $7.23B |
Total Liabilities | $5.80B | $5.31B | Not available | Not available |
Cash & Equivalents | $27.83M | $46.24M | $45.12M | $47.27M |
Free Cash Flow OCF − CapEx | $-42.05M | $328.01M | $138.15M | $151.89M |
Shares Outstanding | 127.69M | 129.64M | 130.85M | 131.75M |